alley igf 1 lr3 IGF-1 Research: Extended Half-Life IGF-1 LR3: Everything You Need
Description
Bethesda, MD: National Institute of Health Office of Dietary Supplements
doi: 10.1016/j.jss.2021.09.005 172 KruitASBrouwersKvan MiddenDZegersHKoersEvan AlfenNet al
The high local potency combined with short half-life offers theoretical advantages over systemic analogs: targeted effects with reduced whole-body exposure and associated risks
Similar content being viewed by others Background Nonalcoholic fatty liver disease (NAFLD) is an important cause of chronic liver injury worldwide [1, 2]
